169 related articles for article (PubMed ID: 7544344)
1. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59.
Lockert DH; Kaufman KM; Chang CP; Hüsler T; Sodetz JM; Sims PJ
J Biol Chem; 1995 Aug; 270(34):19723-8. PubMed ID: 7544344
[TBL] [Abstract][Full Text] [Related]
2. Characterization of rabbit complement component C8. Functional evidence for the species-selective recognition of C8 alpha by homologous restriction factor (CD59).
White RV; Kaufman KM; Letson CS; Platteborze PL; Sodetz JM
J Immunol; 1994 Mar; 152(5):2501-8. PubMed ID: 7510745
[TBL] [Abstract][Full Text] [Related]
3. Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59.
Hüsler T; Lockert DH; Kaufman KM; Sodetz JM; Sims PJ
J Biol Chem; 1995 Feb; 270(8):3483-6. PubMed ID: 7533152
[TBL] [Abstract][Full Text] [Related]
4. Identity of the residues responsible for the species-restricted complement inhibitory function of human CD59.
Zhao XJ; Zhao J; Zhou Q; Sims PJ
J Biol Chem; 1998 Apr; 273(17):10665-71. PubMed ID: 9553129
[TBL] [Abstract][Full Text] [Related]
5. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
Husler T; Lockert DH; Sims PJ
Biochemistry; 1996 Mar; 35(10):3263-9. PubMed ID: 8605162
[TBL] [Abstract][Full Text] [Related]
6. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
8. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
9. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
Lehto T; Meri S
J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
[TBL] [Abstract][Full Text] [Related]
10. Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59.
Chang CP; Hüsler T; Zhao J; Wiedmer T; Sims PJ
J Biol Chem; 1994 Oct; 269(42):26424-30. PubMed ID: 7523406
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity.
Ninomiya H; Stewart BH; Rollins SA; Zhao J; Bothwell AL; Sims PJ
J Biol Chem; 1992 Apr; 267(12):8404-10. PubMed ID: 1373727
[TBL] [Abstract][Full Text] [Related]
12. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
13. Binding of human complement C8 to C9: role of the N-terminal modules in the C8 alpha subunit.
Scibek JJ; Plumb ME; Sodetz JM
Biochemistry; 2002 Dec; 41(49):14546-51. PubMed ID: 12463754
[TBL] [Abstract][Full Text] [Related]
14. Chimeric and truncated forms of human complement protein C8 alpha reveal binding sites for C8 beta and C8 gamma within the membrane attack complex/perforin region.
Plumb ME; Scibek JJ; Barber TD; Dunlap RJ; Platteborze PL; Sodetz JM
Biochemistry; 1999 Jun; 38(26):8478-84. PubMed ID: 10387094
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of CD59: implications for molecular recognition of the complement proteins C8 and C9 in the membrane-attack complex.
Huang Y; Fedarovich A; Tomlinson S; Davies C
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):714-21. PubMed ID: 17505110
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the C8 alpha-gamma and C8 beta subunits of human complement C8: role of the C8 beta N-terminal thrombospondin type 1 module and membrane attack complex/perforin domain.
Musingarimi P; Plumb ME; Sodetz JM
Biochemistry; 2002 Sep; 41(37):11255-60. PubMed ID: 12220191
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
18. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
[TBL] [Abstract][Full Text] [Related]
19. Antisense sequences of 20-kDa homologous restriction factor (HRF20) are found in C9 and the C8 beta chain of homologous complement.
Campbell W; Baranyi L; Okada N; Okada H
Antisense Res Dev; 1993; 3(3):291-4. PubMed ID: 7506958
[TBL] [Abstract][Full Text] [Related]
20. Functional studies of the MACPF domain of human complement protein C8alpha reveal sites for simultaneous binding of C8beta, C8gamma, and C9.
Slade DJ; Chiswell B; Sodetz JM
Biochemistry; 2006 Apr; 45(16):5290-6. PubMed ID: 16618117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
